Grape King Bio (TPE:1707) YoY EBITDA Growth : -9.09% (As of Mar. 2025)

View and export this data going back to 1982. Start your Free Trial

What is Grape King Bio YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Grape King Bio's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -9.09%.

Grape King Bio's EBITDA per Share for the three months ended in Mar. 2025 was NT$3.71.

Grape King Bio YoY EBITDA Growth Historical Data

The historical data trend for Grape King Bio's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grape King Bio YoY EBITDA Growth Chart

Grape King Bio Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

0.89

-6.48

9.82

-0.58

2.12

Grape King Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															-2.74	-0.66	14.04	-2.46	-9.09

Grape King Bio YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Grape King Bio's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(21.385	-	20.942)	/	\| 20.942 \|
=	2.12 %

Grape King Bio's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(3.71	-	4.081)	/	\| 4.081 \|
=	-9.09 %

Grape King Bio YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Grape King Bio's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Grape King Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grape King Bio Ltd (TPE:1707) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 402, Jinling Road, Section 2, Pingzhen District, Taoyuan, TWN, 324

Website

https://www.grapeking.com.tw

Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.

Grape King Bio Headlines

No Headlines